Company intelligence / Profile preview

Tandem Sciences

Ownership: Private
Development stage: Other

Overview

Tandem Life Sciences has achieved significant milestones in the gastroenterology segment with several first-in-India products successfully commercialized. The company is expanding its international presence with a broad portfolio in critical care, gastroenterology, and orthopedics. No detailed clinical trial results are provided.

Therapeutic areas: GastroenterologyRheumatologyOther
Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on Tandem Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tandem Sciences.

Explore the full profile